Hidradenitis Suppurativa
Conditions
Brief summary
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Interventions
None listed
Sponsors
University of California, San Francisco
UCB Pharma
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
10 Years to No maximum
Inclusion criteria
1. Male or female ≥ 10 years of age 2. Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS 3. Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.
Exclusion criteria
1\. Inability to give informed consent or unavailability of a parent/guardian who is able and willing to give informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Primary Objective | 2019-2035 | The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Secondary Objective | 2019-2035 | Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy. |
Countries
United States
Contacts
CONTACTKaelin Chatterley
PRINCIPAL_INVESTIGATORHaley B Naik, MD, MHSc, FAAD
University of California, San Francisco
Outcome results
None listed